Potential Dietary Links to Central Sensitization in Fibromyalgia: Past Reports and Future Directions

Rheumatic Disease Clinics of North America

Volumn 35, Issue 2, 2009, Pages 409-420

  Holton, Kathleen F ^a,b   Kindler, Lindsay L ^c,d   Jones, Kim D ^d  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b UNIVERSITY OF ARIZONA   (United States)

^c KAISER PERMANENTE   (United States)

^d OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

Diet; Dietary intervention; Fibromyalgia; Glutamate; Review

Indexed keywords

AMITRIPTYLINE;

BEHAVIOR THERAPY; BODY MASS; CLINICAL TRIAL; DIET SUPPLEMENTATION; DIET THERAPY; DIETARY INTAKE; DISEASE ASSOCIATION; FIBROMYALGIA; HUMAN; INTERVENTION STUDY; MEDLINE; PRIORITY JOURNAL; REVIEW; SENSITIZATION; VEGETARIAN DIET; WEIGHT REDUCTION;

FIBROMYALGIA; FOOD HABITS; FOOD HYPERSENSITIVITY; HUMANS;

EID: 67651230703     PISSN: 0889857X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rdc.2009.06.003     Document Type: Review

References (56)

1. Russell I.J., Mease P.J., Smith T.R., et al. Efficacy and safety of duloxetine for treatment of fibromyalgia in patients with or without major depressive disorder: results from a 6-month, randomized, double-blind, placebo-controlled, fixed-dose trial. [see comment]. Pain 136 3 (2008) 432-444
2. Russell I.J., Perkins A.T., Michalek J.E., and Oxybate SXB-26 Fibromyalgia Syndrome Study Group. Sodium oxybate relieves pain and improves function in fibromyalgia syndrome: a randomized, double-blind, placebo-controlled, multicenter clinical trial. Arthritis Rheum 60 1 (2009) 299-309
3. Mease P.J., Russell I.J., Arnold L.M., et al. A randomized, double-blind, placebo-controlled, phase III trial of pregabalin in the treatment of patients with fibromyalgia. [see comment]. J Rheumatol 35 3 (2008) 502-514
4. Bennett R., Jones J., Turk D.C., et al. An internet survey of 2,596 people with fibromyalgia. BMC Musculoskelet Disord 8 (2007) 27
5. Lemstra M., and Olszynski W.P. The effectiveness of multidisciplinary rehabilitation in the treatment of fibromyalgia: a randomized controlled trial. Clin J Pain 21 2 (2005) 166-174
6. Haugen M., Kjeldsenkragh J., Nordvag B.Y., et al. Diet and disease symptoms in rheumatic diseases-results of a questionnaire based survey. Clin Rheumatol 10 4 (1991) 401-407
7. Wolfe F., Smythe H.A., Yunus M.B., et al. The American College of Rheumatology 1990 criteria for the classification of fibromyalgia. Report of the Multicenter Criteria Committee. Arthritis Rheum 33 2 (1990) 160-172
8. Michalsen A., Riegert M., Ludtke R., et al. Mediterranean diet or extended fasting's influence on changing the intestinal microflora, immunoglobulin A secretion and clinical outcome in patients with rheumatoid arthritis and fibromyalgia: an observational study. BMC Complement Altern Med 5 (2005) 22
9. Azad K.A., Alam M.N., Haq S.A., et al. Vegetarian diet in the treatment of fibromyalgia. Bangladesh Med Res Counc Bull 26 2 (2000) 41-47
10. Hanninen, Kaartinen K., Rauma A.L., et al. Antioxidants in vegan diet and rheumatic disorders. Toxicology 155 1-3 (2000) 45-53
11. Kaartinen K., Lammi K., Hypen M., et al. Vegan diet alleviates fibromyalgia symptoms. Scand J Rheumatol 29 5 (2000) 308-313
12. Donaldson M.S., Speight N., and Loomis S. Fibromyalgia syndrome improved using a mostly raw vegetarian diet: an observational study. BMC Complement Altern Med 1 (2001) 7
13. Deuster P.A., and Jaffe R.M. A novel treatment for fibromyalgia improves clinical outcomes in a community-based study. J Musculoskeletal Pain 6 2 (1998) 133-149
14. Yunus M.B., Arslan S., and Aldag J.C. Relationship between body mass index and fibromyalgia features. Scand J Rheumatol 31 1 (2002) 27-31
15. Shapiro J.R., Anderson D.A., and Danoff-Burg S. A pilot study of the effects of behavioral weight loss treatment on fibromyalgia symptoms. J Psychosom Res 59 5 (2005) 275-282
16. Hooper M.M., Stellato T.A., Hallowell P.T., et al. Musculoskeletal findings in obese subjects before and after weight loss following bariatric surgery. Int J Obes (Lond) 31 1 (2007) 114-120
17. Yunus M.B. Central sensitivity syndromes: a new paradigm and group nosology for fibromyalgia and overlapping conditions, and the related issue of disease versus illness. Semin Arthritis Rheum 37 6 (2008) 339-352
18. Diatchenko L., Nackley A.G., Slade G.D., et al. Idiopathic pain disorders-pathways of vulnerability. Pain 123 3 (2006) 226-230
19. Marchand S. The physiology of pain mechanisms: from the periphery to the brain. Rheum Dis Clin North Am 34 2 (2008) 285-309
20. Mendell L.M. Physiological properties of unmyelinated fiber projection to the spinal cord. Exp Neurol 16 (1966) 316-332
21. Staud R., and Domingo M. Evidence for abnormal pain processing in fibromyalgia syndrome. Pain Med 2 3 (2001) 208-215
22. Eide P.K. Wind-up and the NMDA receptor complex from a clinical perspective. Eur J Pain 4 (2000) 5-17
23. Mendell L.M., and Wall P.D. Response of singe dorsal cord cells to peripheral cutaneous unmyelinated fibers. Nature 206 (1965) 97-99
24. Stevens B.R. Digestion and absorption of protein. In: Stipanuk M.H. (Ed). Biochemical and physiological aspects of human nutrition (2000), Saunders, Philadelphia 121-122
25. Dingledine R., and Conn P.J. Peripheral glutamate receptors: molecular biology and role in taste sensation. J Nutr 130 4S Suppl (2000) 1039S-1042S
26. Ranney R.E., and Oppermann J.A. A review of the metabolism of the aspartyl moiety of aspartame in experimental animals and man. J Environ Pathol Toxicol 2 4 (1979) 979-985
27. Olney J.W. Excitotoxins in foods. Neurotoxicology 15 3 (1994) 535-544
28. Olney J.W., Ho O.L., Rhee V., et al. Letter: neurotoxic effects of glutamate. N Engl J Med 289 25 (1973) 1374-1375
29. Blaylock R.L. Excitotoxins. The taste that kills (1997), Health Press, Santa Fe, NM
30. Robinson J.S., and Moody R.A. Influence of respiratory stress and hypertension upon the blood-brain barrier. J Neurosurg 53 5 (1980) 666-673
31. Barzo P., Marmarou A., Fatouros P., et al. Magnetic resonance imaging-monitored acute blood-brain barrier changes in experimental traumatic brain injury. J Neurosurg 85 6 (1996) 1113-1121
32. Afonso P.V., Ozden S., Prevost M.C., et al. Human blood-brain barrier disruption by retroviral-infected lymphocytes: role of myosin light chain kinase in endothelial tight-junction disorganization. J Immunol 179 4 (2007) 2576-2583
33. Cohen H., Neumann L., Haiman Y., et al. Prevalence of post-traumatic stress disorder in fibromyalgia patients: overlapping syndromes or post-traumatic fibromyalgia syndrome?. [see comment]. Semin Arthritis Rheum 32 1 (2002) 38-50
34. Pall M.L. Common etiology of posttraumatic stress disorder, fibromyalgia, chronic fatigue syndrome and multiple chemical sensitivity via elevated nitric oxide/peroxynitrite. [see comment]. Med Hypotheses 57 2 (2001) 139-145
35. Toth E., and Lajtha A. Elevation of cerebral levels of nonessential amino acids in vivo by administration of large doses. Neurochem Res 6 12 (1981) 1309-1317
36. Olney J.W., and Sharpe L.G. Brain lesions in an infant rhesus monkey treated with monosodium glutamate. Science 166 903 (1969) 386-388
37. Olney J.W., and Ho O.L. Brain damage in infant mice following oral intake of glutamate, aspartate or cysteine. Nature 227 5258 (1970) 609-611
38. Nemeroff C.B., Grant L.D., Bissette G., et al. Growth, endocrinological, and behavioral deficits after monosodium L-glutamate in the neonatal rat: possible involvement of arcuate dopamine neuron damage. Psychoneuroendocrinology 2 2 (1977) 179-196
39. Nemeroff C.B., Konkol R.J., Bissette G., et al. Analysis of the disruption in hypothalamic-pituitary regulation in rats treated neonatally with monosodium L-glutamate (MSG): evidence for the involvement of tuberoinfundibular cholinergic and dopaminergic systems in neuroendocrine regulation. Endocrinology 101 2 (1977) 613-622
40. Holzwarth M.A., and Hurst E.M. Manifestations of monosodium glutamate (MSG) induced lesions of the arcuate nucleus of the mouse. Anat Rec 178 (1974) 378
41. Hamtsu T. [Effect of sodium iodate and sodium L-glutamate on ERG and histological structure of retina of adult rabbits]. Nippon Ganka Gakkai Zasshi 68 (1964) 1621-1636 [in Japanese]
42. Oser B.L., Carson S., Vogin E.E., et al. Oral and subcutaneous administration of monosodium glutamate to infant rodents and dogs. Nature 229 5284 (1971) 411-413
43. Nagasawa H., Yanai R., and Kikuyama S. Irreversible inhibition of pituitary prolactin and growth hormone secretion and of mammary gland development in mice by monosodium glutamate administered neonatally. Acta Endocrinol 75 2 (1974) 249-259
44. National Academy of Science NRC. Safety and sustainability of MSG and other substances in baby food (Report of Subcommittee) (1970) Washington, DC
45. Larson A.A., Giovengo S.L., Russell I.J., et al. Changes in the concentrations of amino acids in the cerebrospinal fluid that correlate with pain in patients with fibromyalgia: implications for nitric oxide pathways. Pain 87 2 (2000) 201-211
46. Harris R.E., Sundgren P.C., Pang Y., et al. Dynamic levels of glutamate within the insula are associated with improvements in multiple pain domains in fibromyalgia. Arthritis Rheum 58 3 (2008) 903-907
47. Sarchielli P., Di Filippo M., Nardi K., et al. Sensitization, glutamate, and the link between migraine and fibromyalgia. Curr Pain Headache Rep 11 5 (2007) 343-351
48. Peres M.F., Zukerman E., Senne Soares C.A., et al. Cerebrospinal fluid glutamate levels in chronic migraine. Cephalalgia 24 9 (2004) 735-739
49. Smith J.D., Terpening C.M., Schmidt S.O., et al. Relief of fibromyalgia symptoms following discontinuation of dietary excitotoxins. Ann Pharmacother 35 6 (2001) 702-706
50. Ogden C.L., Carroll M.D., McDowell M.A., et al. Obesity among adults in the United States-no change since 2003-2004 (2007), National Center for Health Statistics, Hyattsville (MD)
51. Nagata M., Suzuki W., Iizuka S., et al. Type 2 diabetes mellitus in obese mouse model induced by monosodium glutamate. Exp Anim 55 2 (2006) 109-115
52. Bunyan J., Murrell E.A., and Shah P.P. The induction of obesity in rodents by means of monosodium glutamate. Br J Nutr 35 1 (1976) 25-39
53. Morrison J.F., Shehab S., Sheen R., et al. Sensory and autonomic nerve changes in the monosodium glutamate-treated rat: a model of type II diabetes. Exp Physiol 93 2 (2008) 213-222
54. He K., Zhao L., Daviglus M.L., et al. Association of monosodium glutamate intake with overweight in Chinese adults: the INTERMAP study. Obesity 16 8 (2008) 1875-1880
55. Podovei M., and Kuo B. Irritable bowel syndrome: a practical review. South Med J 99 11 (2006) 1235-1242
56. Bradley L.A. Pathophysiologic mechanisms of fibromyalgia and its related disorders. J Clin Psychiatry 69 Suppl 2 (2008) 6-13